Humana Inc. (NYSE:HUM) Receives Consensus Recommendation of "Hold" from Brokerages

Key Points

• Humana Inc. has received a consensus recommendation of "Hold" from 23 analysts, with 16 ratings as hold and 7 as buy, and an average one-year target price of $289.24.
• Institutional investors, including Vanguard and Dodge & Cox, have recently increased their stakes in Humana, with hedge funds and institutions collectively owning 92.38% of the company's stock.
• Humana announced a quarterly dividend of $0.885 per share, representing a yield of 1.3%, with the ex-dividend date on September 26.

Shares of Humana Inc. (NYSE:HUM - Get Free Report) have earned a consensus recommendation of "Hold" from the twenty-three analysts that are covering the firm, Marketbeat reports. Sixteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $289.2381.

HUM has been the topic of several research analyst reports. Piper Sandler lowered their price target on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Wall Street Zen cut Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Wells Fargo & Company dropped their target price on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a research report on Thursday, August 14th. Sanford C. Bernstein boosted their price target on Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Finally, Robert W. Baird reduced their price target on shares of Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research report on Friday, July 25th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of HUM. Vanguard Group Inc. grew its position in shares of Humana by 1.6% during the 2nd quarter. Vanguard Group Inc. now owns 14,199,096 shares of the insurance provider's stock valued at $3,471,395,000 after acquiring an additional 226,224 shares during the period. Dodge & Cox lifted its position in Humana by 5.6% during the second quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider's stock valued at $2,775,562,000 after purchasing an additional 597,705 shares in the last quarter. State Street Corp grew its holdings in Humana by 1.1% during the second quarter. State Street Corp now owns 5,377,390 shares of the insurance provider's stock valued at $1,319,334,000 after purchasing an additional 58,094 shares during the period. Pzena Investment Management LLC increased its position in Humana by 6.5% in the second quarter. Pzena Investment Management LLC now owns 4,076,667 shares of the insurance provider's stock worth $996,664,000 after buying an additional 247,744 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in Humana by 1.9% in the second quarter. Geode Capital Management LLC now owns 3,130,829 shares of the insurance provider's stock worth $762,233,000 after buying an additional 57,267 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Price Performance

HUM opened at $279.04 on Friday. The company's 50-day simple moving average is $264.58 and its two-hundred day simple moving average is $257.07. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The stock has a market capitalization of $33.56 billion, a P/E ratio of 21.42, a P/E/G ratio of 1.61 and a beta of 0.44. Humana has a 52-week low of $206.87 and a 52-week high of $331.00.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business's revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, analysts predict that Humana will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana's dividend payout ratio is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.